Digital pathology
Paige
Digital pathology AI applications for cancer pathology, including Paige Prostate.
Last updated: May 25, 2026
Back to directoryVisiopharm medical AI product profile
Precision pathology software company offering AI image-analysis workflows, IVDR-certified diagnostic APPs, research tools, and integration paths with pathology platforms.
Digital pathology
Best fit
Labs and research teams evaluating AI-assisted biomarker scoring, tissue quantification, companion-diagnostic support, and interoperable pathology image analysis.
- Primary use case
- AI-driven precision pathology image analysis, biomarker scoring, diagnostic decision support APPs, research analysis, and workflow integrations
- Audience
- Diagnostic pathology labs, translational research teams, biopharma pathology groups, and precision-pathology programs
- Risk level
- High
- Pricing signal
- Enterprise diagnostic, research, and biopharma pricing; request current APP, platform, integration, and regional terms.
- Official sources
- 5 official sources
Compare within workflow: Digital pathology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
product-specific source-backed lens: These product-specific signals summarize what the cited sources imply before treating Visiopharm as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat each APP independently because diagnostic, IVDR-certified, CE-IVD, RUO, EU/UK, U.S., and partner-integration status can differ by use case. |
|---|---|
| Privacy | Verify data-processing agreements, customer-data roles, image storage, cloud or local deployment, research-data sharing, access controls, retention, and partner-platform data paths. |
| Evidence | Review APP-level validation for tissue, stain, biomarker threshold, scanner, laboratory population, performance evaluation, and post-market follow-up before clinical use. |
| Workflow | Best used where AI outputs remain reviewable inside existing pathology platforms and where lab teams can govern APP selection, batch processing, QA, and signout. |
Where Visiopharm fits
Visiopharm describes AI-driven precision pathology software for research and diagnostics, including IVDR-certified CE-IVD diagnostic APPs, research image-analysis tools, and integration workflows with image-management systems; its privacy policy describes customer and website data processing separately from deployment-specific diligence.
Not for: Applying CE-IVD or IVDR claims outside the exact APP, region, tissue, biomarker, scanner, and intended-use scope.
What to verify before using Visiopharm
- Which Visiopharm platform or APP is in scope: diagnostic decision support, Discovery, Phenoplex, Qualitopix, or a partner integration.
- IVDR, CE-IVD, RUO, EU/UK, U.S., scanner, stain, tissue, and biomarker status for each APP.
- How images, annotations, customer data, research datasets, and customer personal data are handled under privacy and processing terms.
- How pathologists or scientists review AI masks, biomarker scores, QA flags, batch runs, exceptions, and final diagnostic or research conclusions.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- visiopharm.com
- visiopharm.com / diagnostics-pathology-image-analysis-software
- visiopharm.com / press-releases / visiopharm-products-now-ivdr-certified
- visiopharm.com / press-releases / visiopharms-precision-pathology-apps-to-be-integrated-with-pathais-aisight-image-management-system
- visiopharm.com / privacypolicy
Related medical AI products
Digital pathology
Digital pathology
PathAI
AI-enabled digital pathology platform with image management and algorithm access.
Digital pathology
Ibex Medical Analytics
Clinical-grade AI pathology platform for cancer diagnostics and pathology workflow support.
Digital pathology
Proscia
Concentriq digital pathology platform that supports diagnostic, research, and AI-enabled pathology workflows.